Product Images Chlorpromazine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Chlorpromazine Hydrochloride NDC 70710-1850 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 97106093 2f0a 4cc9 b580 942b015c6c5b 01

Image - 97106093 2f0a 4cc9 b580 942b015c6c5b 01

1ml container - 97106093 2f0a 4cc9 b580 942b015c6c5b 02

1ml container - 97106093 2f0a 4cc9 b580 942b015c6c5b 02

1ml carton - 97106093 2f0a 4cc9 b580 942b015c6c5b 03

1ml carton - 97106093 2f0a 4cc9 b580 942b015c6c5b 03

This is a description of a pharmaceutical product, Chlorpromazine Hydrochloride Injection, USP, intended for deep intramuscular use. Each mL contains chlorpromazine hydrochloride USP, 25 mg, ascorbic acid 2 mg, sodium metabisulfite 1 mg, sodium sulfite 1 mg, and sodium chloride 6 mg in water for injection. The usual dosage instructions are provided in the package insert. It is important to protect the product from light and keep it covered in the carton until use. Storage conditions include 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) to avoid freezing. The product information includes details on substrate, special instructions, and form of supply. The manufacturing details indicate it is made by Zydus Lifesciences Ltd and distributed by Zydus Pharmaceuticals (USA) Inc. *

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.